CLINICAL_TRIALS
trial_result
· 2018-11-14
Clinical Trial Update: Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B [Phase 1, Phase 2]
Summary
A safety and dose-finding study of DTX101 (AAVrh10FIX) in adults with Hemophilia B was terminated; results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ultragenyx Pharmaceutical Inc | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-11-14